S&P 500   4,957.13 (-1.08%)
DOW   37,869.42 (+0.25%)
QQQ   415.59 (-1.85%)
AAPL   164.79 (-1.35%)
MSFT   399.03 (-1.30%)
META   480.43 (-4.26%)
GOOGL   153.65 (-1.51%)
AMZN   174.04 (-2.89%)
TSLA   147.27 (-1.77%)
NVDA   778.40 (-8.07%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.44 (-2.94%)
CGC   8.03 (+2.55%)
DIS   112.25 (-0.16%)
AMC   3.17 (+8.56%)
PFE   25.89 (+1.97%)
PYPL   61.86 (-0.39%)
XOM   119.71 (+1.00%)
S&P 500   4,957.13 (-1.08%)
DOW   37,869.42 (+0.25%)
QQQ   415.59 (-1.85%)
AAPL   164.79 (-1.35%)
MSFT   399.03 (-1.30%)
META   480.43 (-4.26%)
GOOGL   153.65 (-1.51%)
AMZN   174.04 (-2.89%)
TSLA   147.27 (-1.77%)
NVDA   778.40 (-8.07%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.44 (-2.94%)
CGC   8.03 (+2.55%)
DIS   112.25 (-0.16%)
AMC   3.17 (+8.56%)
PFE   25.89 (+1.97%)
PYPL   61.86 (-0.39%)
XOM   119.71 (+1.00%)
S&P 500   4,957.13 (-1.08%)
DOW   37,869.42 (+0.25%)
QQQ   415.59 (-1.85%)
AAPL   164.79 (-1.35%)
MSFT   399.03 (-1.30%)
META   480.43 (-4.26%)
GOOGL   153.65 (-1.51%)
AMZN   174.04 (-2.89%)
TSLA   147.27 (-1.77%)
NVDA   778.40 (-8.07%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.44 (-2.94%)
CGC   8.03 (+2.55%)
DIS   112.25 (-0.16%)
AMC   3.17 (+8.56%)
PFE   25.89 (+1.97%)
PYPL   61.86 (-0.39%)
XOM   119.71 (+1.00%)
S&P 500   4,957.13 (-1.08%)
DOW   37,869.42 (+0.25%)
QQQ   415.59 (-1.85%)
AAPL   164.79 (-1.35%)
MSFT   399.03 (-1.30%)
META   480.43 (-4.26%)
GOOGL   153.65 (-1.51%)
AMZN   174.04 (-2.89%)
TSLA   147.27 (-1.77%)
NVDA   778.40 (-8.07%)
AMD   146.30 (-5.66%)
NIO   3.80 (-5.00%)
BABA   68.93 (+0.07%)
T   16.48 (+0.92%)
F   12.07 (+0.08%)
MU   106.32 (-5.01%)
GE   148.44 (-2.94%)
CGC   8.03 (+2.55%)
DIS   112.25 (-0.16%)
AMC   3.17 (+8.56%)
PFE   25.89 (+1.97%)
PYPL   61.86 (-0.39%)
XOM   119.71 (+1.00%)
Free Trial

Cellebrite DI (CLBT) SEC Filings & 10K Form

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)
Free CLBT Stock Alerts
$10.43
+0.05 (+0.48%)
(As of 02:40 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Recent Cellebrite DI SEC Filings

Export to Excel
DateFilerForm TypeView
04/12/2024
4:03 PM		Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 20-F/A
03/21/2024
8:10 AM		Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/21/2024
6:10 AM		Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/15/2024
3:17 PM		Carmil Yosef (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2024
11:38 AM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP SAFERWORLD, LIMITED PARTNERSHIP (Filed by)
Form SC 13G/A
03/06/2024
6:15 AM		Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2024
3:36 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/23/2024
5:02 AM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP Investments , LP (0002002785) (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/22/2024
3:21 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
4:23 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Utsumi Ryusuke (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/15/2024
6:15 AM		Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/08/2024
4:14 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP SAFERWORLD, LIMITED PARTNERSHIP (Filed by)
Form SC 13G/A
02/08/2024
3:10 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Cole Lisa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/08/2024
8:07 AM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
SUNCORPORATION (Filed by)
Form SC 13G/A
01/11/2024
6:14 AM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP SaferWorld, LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/28/2023
5:35 AM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP SaferWorld, LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2023
6:51 AM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP SaferWorld, LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/14/2023
3:31 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
SHANI HAIM (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
6:57 AM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP SaferWorld, LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2023
3:19 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2023
10:20 AM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP Investments , LP (0002002785) (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
6:55 AM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP Investments , LP (0002002785) (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
3:30 PM		Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/01/2023
5:38 AM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
IGP Investments , LP (0002002785) (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/28/2023
3:15 PM		Armon Ronnen (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2023
4:57 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Cole Lisa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2023
3:21 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
3:20 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
3:20 PM		Armon Ronnen (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
3:22 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2023
3:12 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Cole Lisa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2023
3:49 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2023
6:39 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Teegardin Marque (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2023
6:20 PM		Basore Ken (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2023
3:33 PM		Carmil Yosef (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2023
3:33 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2023
3:36 PM		Armon Ronnen (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2023
3:13 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Veinstein Arthur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2023
3:17 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2023
3:46 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2023
3:40 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story
08/29/2023
3:50 PM		Armon Ronnen (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2023
3:25 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/25/2023
3:18 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/24/2023
3:11 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Teegardin Marque (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/24/2023
3:14 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2023
3:51 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2023
3:24 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Teegardin Marque (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2023
4:03 PM		Armon Ronnen (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2023
3:26 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2023
3:25 PM		Armon Ronnen (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
4:16 PM		Armon Ronnen (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
3:53 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/10/2023
4:32 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Veinstein Arthur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2023
6:05 AM		Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/08/2023
6:10 AM		Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2023
3:16 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/21/2023
3:05 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2023
3:09 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2023
3:01 PM		Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2023
3:35 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/30/2023
4:01 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2023
3:23 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/27/2023
4:05 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Tirosh Osnat (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/27/2023
3:07 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/27/2023
3:08 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2023
3:19 PM		Ben-Peretz Leeor (Reporting)
Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2023
3:21 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Gerner Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2023
4:10 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Tirosh Osnat (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2023
4:39 PM		Cellebrite DI (Subject)
Cellebrite DI Ltd. (Subject)
Tirosh Osnat (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/10/2023
6:40 AM		Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/27/2023
6:13 AM		Cellebrite DI (Filer)
Cellebrite DI Ltd. (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:CLBT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
My biggest AI fear
Paradigm Press